Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Maze Therapeutics, Inc. - Common Stock (NQ:MAZE)

24.80 +8.78 (+54.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, Sep 11, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Maze Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >
What's going on in today's session
Curious to know what's happening on the US markets one hour before the close of the markets on Thursday? Join us as we explore the top gainers and losers in today's session. 
Via Chartmill
Maze Shares Jump As Investors Bet Big On Experimental Treatment's Potential
Maze's MZE782 showed strong Phase 1 results, supporting once- or twice-daily dosing with increased amino acid excretion and no serious side effects. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
 
Via Benzinga
Which stocks are moving on Thursday?
Looking for insights into the US markets in the middle of the day on Thursday? Delve into the top gainers and losers of today's session and gain valuable market intelligence. 
Via Chartmill
Maze Therapeutics, Opendoor Technologies, Oxford Industries, VNET Group And Other Big Stocks Moving Higher On Thursday
 
Via Benzinga
Thursday's session: gap up and gap down stocks
Let's have a look at the gap up and gap down stocks in today's session. 
Via Chartmill
Why Maze Therapeutics, Up 51%, Was Shocked By Its Own Test Results
Shares catapulted Thursday after its experimental treatment for a rare, genetic disease blew past expectations. 
Via Investor's Business Daily
Discover the top movers in Thursday's pre-market session.
As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment. 
Via Chartmill
12 Health Care Stocks Moving In Thursday's Pre-Market Session
 
Via Benzinga
Maze Therapeutics Announces Oversubscribed $150.0 Million Private Placement
From Maze Therapeutics, Inc.
Via GlobeNewswire
Maze Therapeutics Announces Positive First-in-Human Results from Phase 1 Trial of MZE782, Establishing Proof of Mechanism for a Potent, Oral SLC6A19 Inhibitor with Potential to Treat Phenylketonuria (PKU) and Chronic Kidney Disease (CKD)
From Maze Therapeutics, Inc.
Via GlobeNewswire
Maze Therapeutics Appoints Misbah Tahir as Chief Financial Officer
From Maze Therapeutics, Inc.
Via GlobeNewswire
Maze Therapeutics Inc (NASDAQ:MAZE) Reports Narrower Q2 2025 Loss, Extends Cash Runway to 2027
Maze Therapeutics reports Q2 2025 earnings with a narrower loss than expected, extends cash runway to 2027, and advances kidney disease clinical trials. 
Via Chartmill
Maze Therapeutics Reports Second Quarter 2025 Financial Results and Recent Highlights
From Maze Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
 
Via Benzinga
This Celsius Holdings Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday
 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
 
Via Benzinga
Maze Therapeutics to Participate in Two Upcoming Investor Conferences
From Maze Therapeutics, Inc.
Via GlobeNewswire
Maze Therapeutics to Participate in the Jefferies 2025 Global Healthcare Conference
From Maze Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
 
Via Benzinga
Maze Therapeutics Reports First Quarter 2025 Financial Results and Reiterates Upcoming Milestones
From Maze Therapeutics, Inc.
Via GlobeNewswire
Maze Therapeutics to Participate in the 3rd Annual H.C. Wainwright BioConnect Investor Conference
From Maze Therapeutics, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Booz Allen Hamilton, Movado Group And Other Big Stocks Moving Lower In Friday's Pre-Market Session
 
Via Benzinga
Why Argenx Shares Are Trading Higher By 5%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Why Chanson International Holding Shares Are Trading Higher By Around 170%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
 
Via Benzinga
Maze Therapeutics Reports Fourth Quarter and Full-Year 2024 Financial Results and Recent Highlights
From Maze Therapeutics, Inc.
Via GlobeNewswire
JOYY, Akebia Therapeutics, Microchip Technology And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
 
Via Benzinga
< Previous 1 2 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.